Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Ann Oncol. 2010 May:21 Suppl 5:v162-4. doi: 10.1093/annonc/mdq180.

Authors

B Eichhorst¹, M Hallek, M Dreyling; ESMO Guidelines Working Group

Affiliation

¹ Department of Internal Medicine I, University of Köln, Germany.

PMID: 20555070
DOI: 10.1093/annonc/mdq180

No abstract available

Publication types

Practice Guideline
Research Support, Non-U.S. Gov't

MeSH terms

Antigens, CD19 / metabolism
Antigens, CD20 / metabolism
CD5 Antigens / metabolism
Drug Therapy*
Europe / epidemiology
Follow-Up Studies
Humans
Immunotherapy*
In Situ Hybridization, Fluorescence
Incidence
Leukemia, Lymphocytic, Chronic, B-Cell / diagnosis*
Leukemia, Lymphocytic, Chronic, B-Cell / pathology
Leukemia, Lymphocytic, Chronic, B-Cell / therapy*
Neoplasm Staging
Prognosis
Receptors, IgE / metabolism
Risk Assessment
Secondary Prevention
Stem Cell Transplantation
Treatment Outcome

Substances

Antigens, CD19
Antigens, CD20
CD5 Antigens
Receptors, IgE